The Need for Treatment of Neovascular Age-Related Macular Degeneration: A Study Based on the Polish National Registry.
Sławomir Jan TeperAnna NowińskaMałgorzata FigurskaMarek RękasEdward WylęgałaPublished in: Ophthalmology and therapy (2022)
The need for nAMD treatment in the elderly community (65 years of age and older) is estimated to be 0.55-0.66%.